Related Experiment Video
Updated: Jul 18, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
The smallest suffer stroke: Understanding stroke and treatment patterns in children with blunt cerebrovascular injury
Catherine C Dawson-Gore1, Emily K Myers1, Emily H Cooper2
1Division of Pediatric Surgery, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Insights
Pediatric blunt cerebrovascular injury (BCVI) treatment patterns are unclear. Young children with BCVI had higher stroke rates and received less antithrombotic therapy, necessitating treatment guidelines.
Area of Science:
- Pediatric Traumatology
- Vascular Neurology
- Pediatric Critical Care
Background:
- Blunt cerebrovascular injury (BCVI) in children is uncommon but carries significant risk.
- Current treatment patterns and stroke rates associated with BCVI in pediatric populations are not well-defined.
- Optimal timing and use of antithrombotic therapy for pediatric BCVI remain unknown.
Purpose of the Study:
- To describe stroke rates and treatment patterns in children with blunt cerebrovascular injury.
- To compare treatment strategies and outcomes across different age groups and injury severities.
- To identify knowledge gaps regarding antithrombotic therapy in pediatric BCVI.
Main Methods:
- Retrospective review of the Trauma Quality Improvement Program database (2016-2022).
- Inclusion of pediatric patients (<18 years) with blunt injury and diagnosed BCVI.
- Analysis of stroke rates and antithrombotic use, with subgroup analysis excluding traumatic brain injury and contraindications to therapy.
Main Results:
- A total of 2,336 pediatric BCVI cases (0.34%) were identified among 685,631 blunt injuries.
- Stroke rates were highest in the youngest children (0-6 years: 6.2%) who received antithrombotic therapy least often.
- Patients receiving antithrombotic therapy had higher stroke rates (6.1%) compared to untreated patients (2.1%), potentially indicating delayed treatment initiation.
Conclusions:
- Children aged 0-11 years with BCVI experienced the highest stroke rates and were least likely to receive antithrombotic therapy.
- Over half of pediatric BCVI patients did not receive antithrombotic therapy.
- The finding that treated patients had higher stroke rates suggests a need for standardized treatment guidelines to optimize antithrombotic use in pediatric BCVI.
Background:
Stroke rate and treatment patterns for children with blunt cerebrovascular injury are not well-described. There exists a gap in knowledge of how children with blunt cerebrovascular injury are treated, the stroke rate associated with antithrombotic therapy, and the optimal time to start treatment.
Methods:
A retrospective review of the Trauma Quality Improvement Program database was conducted from 2016 to 2022 for children with blunt injury (<18 years) with blunt cerebrovascular injury. Analysis of all children with blunt cerebrovascular injury and subgroups of children without traumatic brain injury, as well as those without contraindications to antithrombotic therapy (no traumatic brain injury, solid-organ injury, or blood transfusion within 24 hours) was performed. Stroke rate and treatment patterns were compared between age groups (0-6, 7-11, 12-14, 15-17 years) and injury grades.
Results:
Among 685,631 blunt injured children, 2,336 incurred blunt cerebrovascular injury (0.34%). Stroke rate was greatest in the youngest patients (6.2% 0-6 years; 2.0% 7-11 years) who had the lowest rates of antithrombotic therapy. Fifty-two percent of patients received no antithrombotic therapy during their hospitalization. Children who received antithrombotic therapy had greater rates of stroke compared with those untreated (6.1% vs 2.1%, P < .001) regardless of age group. Low-molecular weight heparin was the most common antithrombotic therapy (28.2%) followed by heparin (14.2%), and aspirin (5.1%).
Conclusion:
Children aged 0-11 years had the greatest rates of stroke and were least likely to receive antithrombotic therapy. More than one half of children did not receive antithrombotic therapy. Patients who received antithrombotic therapy had greater stroke rates than untreated patients, which may reflect antithrombotic therapy given after stroke occurred. Treatment guidelines are needed for children with blunt cerebrovascular injury.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Traumatic Brain Injury l: Introduction

